Brief: Lee's Pharmaceutical Holdings - QTRLY Revenue HK$283.7 Mln Versus HK$324.6 Mln
27/08/2020 10:08
Aug 27 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY REVENUE HK$283.7 MILLION VERSUS HK$324.6 MILLION
* QTRLY PROFIT ATTRIBUTABLE HK$57.1 MILLION VERSUS LOSS OF
HK$8.7
MILLION
* RECOMMENDED AN INTERIM DIVIDEND OF HK$0.027 PER SHARE
* GROUP FORESEES TOUGH ENVIRONMENT WILL BE PERSISTED
THROUGHOUT
THIS YEAR
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7FcQ68
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals